TrialAnnals of the rheumatic diseases2009

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.

J Smolen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.